Calcium D3 Myopharm

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.003593.08.17
Date of registration and renewal:11.08.2017
Dosage form: & nbspChewable tablets weighing 2.2 ± 0.11 g.
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes Supplements - macro and microelements BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp BAD-source of monovitamins and vitamin-like substances Supplements containing calcium and phosphorus
Composition: & nbspCalcium carbonate, Е420, Е460i, potato starch, Е110, Е551, gelatin, Е470, vitamin D3, Е951.
Scope: & nbspFor realization to the population as a biologically active additive to food - an additional source of vitamin D3 and calcium.
Suggested Usage: & nbspAdults take 1 chewable tablet 2 times a day, with meals. Duration of admission is 1 month.
Contraindications:Individual intolerance of components, pregnancy, phenylketonuria.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Stored in a dry place, protected from direct sunlight and the reach of children at a temperature not higher than 25 ° C.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.E.000637.02.17 of 09.02.2017, the expert opinion of FGBUN "FIC of power and safety" No. 529 / E-09 / b-17 of 12/01/2017.
Recipient:Miofarm, Open CompanyMiofarm, Open Company Russian Federation
Information update date: & nbsp05.11.2017
Instructions
Up